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Digoxin-induced retinal degeneration depends on
rhodopsin
Britta Landfried1, Marijana Samardzija1, Maya Barben1,2, Christian Schori1,3, Katrin Klee1,3, Federica Storti1 and Christian Grimm*,1,2,3
Na,K-ATPases are energy consuming ion pumps that are required for maintaining ion homeostasis in most cells. In the retina,
Na,K-ATPases are especially important to sustain the dark current in photoreceptor cells needed for rapid hyperpolarization of
rods and cones in light. Cardiac glycosides like digoxin inhibit the activity of Na,K-ATPases by targeting their catalytic alpha
subunits. This leads to a disturbed ion balance, which can affect cellular function and survival. Here we show that the treatment of
wild-type mice with digoxin leads to severe retinal degeneration and loss of vision. Digoxin induced cell death specifically in
photoreceptor cells with no or only minor effects in other retinal cell types. Photoreceptor-specific cytotoxicity depended on the
presence of bleachable rhodopsin. Photoreceptors of Rpe65 knockouts, which have no measurable rhodopsin and photoreceptors
of Rpe65R91W mice that haveo10% of the rhodopsin found in retinas of wild-type mice were not sensitive to digoxin treatment.
Similarly, cones in the all-cone retina of Nrl knockout mice were also not affected. Digoxin induced expression of several genes
involved in stress signaling and inflammation. It also activated proteins such as ERK1/2, AKT, STAT1, STAT3 and CASP1 during a
period of up to 10 days after treatment. Activation of signaling genes and proteins, as well as the dependency on bleachable
rhodopsin resembles mechanisms of light-induced photoreceptor degeneration. Digoxin-mediated photoreceptor cell death may
thus be used as an inducible model system to study molecular mechanisms of retinal degeneration.
Cell Death and Disease (2017) 8, e2670; doi:10.1038/cddis.2017.94; published online 16 March 2017
Retinal degenerative diseases like retinitis pigmentosa or
age-related macular degeneration (AMD) lead to strong visual
impairment or blindness and have a high socio-economic
impact. Although they affect a large number of patients and the
incidence is expected to increase during the next decades
especially for AMD,1 an efficient treatment option is still an
unmet medical need. A main reason for the lack of therapies is
the insufficient understanding of the pathophysiological
mechanisms responsible for disease initiation and progres-
sion even though many animal models have been developed
and studied.2 These models are either based on genetic
manipulations or on the application of toxic stimuli such as
light3 or N-methyl-N-nitrosourea (MNU)4 andmay give insights
into specific aspects of disease pathology. Nevertheless,
additional models based on different molecules or pathways
are desirable to further broaden approaches and experimental
possibilities for investigations.
Cardiac glycosides like digoxin or ouabain inhibit
Na,K-ATPases and are traditionally used to treat atrial
fibrillation and atrial flutter.5 Owing to their cytotoxic properties,
they are also discussed as possible anticancer agents.6
Although different cardiac glycosides have slightly different
specificities for different isoforms of the Na,K-ATPases,7 their
inhibitory action on the ion pump causes increased intracel-
lular Na+ and Ca2+ and decreased K+ concentrations.8 This
disturbance of the ion homeostasis may affect cellular function
and viability. As cardiac glycosides inhibit Na,K-ATPases in all
tissues including the retina, it is not surprising that several
reports suggest an effect of digoxin on vision, with strongest
disturbances of the cone pathway.9,10
Na,K-ATPases are heterodimers, composed of an alpha-
and a beta-subunit.11 In addition, they can be regulated by an
auxiliary FXYD protein.12,13 Cardiac glycosides target primar-
ily the catalytic alpha subunit of the Na,K-ATPase.14,15 Four
alpha subunits have been identified that are encoded by
different genes (Atp1a1–Atp1a4) and show tissue-specific
expression. Whereas α1 is quite ubiquitously expressed in
many tissues including the retina, α2 and α3 show a more
specific pattern and have also been found in brain and
retina.16 Whereas α2 may be specific for Müller glia cells, α3
has been identified on all retinal neurons with particularly
strong expression in photoreceptors, but not on Müller cells or
the retinal pigment epithelium (RPE).17 In contrast, α4 may be
restricted to testis where it is important for spermmaturation.18
Since digoxin shows some preference for α2 and α3
isoforms7 it may affect activity of Na,K-ATPases in the retina.
Reports of patients describing visual disturbances, blurred
vision, central scotomas or seeing yellowish19 after digoxin
treatment support this conclusion. Similarly, studies in
monkeys demonstrated that digoxin can affect function
especially of the cone system,10 and a recent report showed
that treating mice with high doses of digoxin causes retinal
degeneration.20 Thus, we investigated the effect of digoxin on
the mouse retina and focused on its potential cytotoxicity for
photoreceptor cells in different wild type and transgenicmouse
lines. We established a treatment protocol that induces severe
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loss of photoreceptors and propose that digoxin-mediated
photoreceptor cell death may be used as a novel model to
study mechanisms of retinal degeneration.
Results
Digoxin-induced retinal degeneration. To characterize the
morphological, functional and molecular response to digoxin
treatment, we titrated the amount of digoxin and the number
of intraperitoneal (ip) injections needed for the induction of
photoreceptor degeneration in C57BL/6 mice. In a first set of
experiments, we used a dose of 2 mg/kg that was reported by
Hinshaw et al.20 to cause photoreceptor degeneration after 5
(least number of injections reported) or more intraperitoneal
injections. This dose induced severe retinal degeneration
already after three daily ip injections whereas one and two
injections did not noticeably alter retinal morphology
(Figure 1a). Although the extent of degeneration was slightly
variable, cell death was largely restricted to the outer nuclear
layer (ONL) as almost no TUNEL-positive cells were detected
in other retinal layers (Figure 1a). Three injections of a lower
dose (up to 1 mg/kg) did not cause degeneration (Figure 1b).
Consequently, a treatment protocol of one digoxin injection on
each of three consecutive days at a dose of 2 mg/kg was
established and used for most of the following experiments.
Although strong morphological damage was observed at
2 days, we detected pyknotic nuclei in the ONL as early as
1 day after the last injection (Figure 1c, white arrowheads).
This was followed by a complete disruption of the outer and
inner segments and loss of photoreceptors in the central
retina between 2 and 10 days, the last time point analyzed
(Figure 1c). Degeneration was accompanied by macrophage
infiltration to the subretinal space (Figure 1c, black arrow).
Loss of photoreceptor cells was most significant in the central
retina whereas the retinal periphery was largely spared
(Figures 2a and 6f). Consequences of digoxin treatment were
also followed in vivo by fundus photography and optical
coherence tomography (OCT) at 9 days after treatment
(Figure 2b). Injections of digoxin caused the fundus to appear
more intensely pigmented, probably due to the thinned retinal
tissue. OCT images confirmed severe thinning of the ONL in
digoxin-treated but not in control mice. Some regions of the
retina in digoxin-treated mice were detached from the
RPE suggesting potential subretinal fluid accumulation
(Figure 2b).
TUNEL staining (Figure 1a) suggested that the toxic effect
of digoxin was largely restricted to photoreceptor cells. This
conclusion was further supported by immunofluorescence
staining of retinal cell markers in retinas at 10 days after
digoxin or PBS treatment. Distribution of peanut agglutinin
(PNA) and G-protein subunit alpha transducin 1 (GNAT1)
showed that both cones and rods were directly or indirectly
affected by digoxin (Figure 3a). In contrast, normal distribution
of visual system homeobox 2 (VSX2), pou domain, class4,
transcription factor 1 (POU4F1), calbindin 1 (CALB1) and
calretinin (CR) suggested that bipolar cells, ganglion cells,
horizontal cells and amacrine cells, respectively, were largely
unaffected (Figures 3b and c). Nevertheless, digoxin induced
degeneration of photoreceptors activated Müller glia cells as
indicated by increased GFAP staining and stimulated resident
IBA1-positive microglia and/or macrophages to migrate to the
subretinal space (Figure 3d).
As expected, digoxin-induced loss of photoreceptors
affected scotopic and photopic retinal function at 10 days after
treatment. Scotopic and photopic b-wave, as well as scotopic
a-wave amplitudes were reduced indicating loss of function
(Figures 4a and c). Even though morphological and immuno-
fluorescence analyses suggested that digoxin toxicity was
confined to photoreceptors in the outer retina, cells of the inner
retina may have been affected functionally. ERG recordings
one day after two digoxin injections (2 mg/kg), a treatment that
did not induce photoreceptor degeneration (Figure 1a),
showed prolonged responses at low light intensities, a
reduction of the maximal b-wave amplitudes and strongly
reduced oscillatory potentials for both the scotopic and the
photopic ERG (Figures 4b and c). These observations
resemble functional consequences reported for ocular
ischemia21 that is characterized by a reduced supply of
oxygen to the inner retina.22 Interestingly, digoxin can reduce
heart rate23 and cause vasoconstriction of peripheral
arteries,24 and may thus potentially lead to a reduced blood
flow in peripheral organs including the retina. Clearly, further
experimentation is required to evaluate the influence of digoxin
on retinal function.
Molecular signaling. Digoxin inhibits Na,K-ATPases25
through interaction with the regulatory alpha subunits, with
a preference for α2 and α3 (ref. 26) (see ‘Introduction’
section). As α4 was reported to be specifically expressed in
testis,18 we focused on α1, α2 and α3 for our analysis. As
reported before17 all three alpha subunits were expressed in
the normal mouse retina (Figure 5a). Treatment with digoxin
increased expression of Atp1a1 at 1 d and 10 d, did not affect
Atp1a2 and reduced the expression of Atp1a3 (Figure 5a). As
α3 shows a strong expression in photoreceptors whereas α1
and α2 may be expressed preferentially by other retinal
cells,17 downregulation of Atp1a3 expression may reflect the
degenerative process with photoreceptor injury and death. In
addition, digoxin treatment induced retinal expression of
several genes involved in stress signaling such as
endothelin-2 (Edn2), fibroblast growth factor 2 (Fgf2) and
glial fibrillary acidic protein (Gfap), in degeneration and
inflammation including caspase 1 (Casp1) and tumor
necrosis factor alpha (Tnf), and in oxidative stress like heme
oxygenase 1 (Hmox1; Figure 5b). Peak of activation was at
2 days after the last digoxin injection. Expression levels
returned to basal levels at 10 days after injections suggesting
a general recovery from treatment. This interpretation was
supported by the pattern of protein activation (Figure 5c).
Phosphorylation of the signaling proteins extracellular signal
regulated kinase (ERK), protein kinase B (alias AKT), signal
transducer and activator of transcription 1 (STAT1) and of
STAT3 peaked at 1 and 2 days after treatment, reaching
basal levels thereafter. Interestingly, we consistently
observed that levels of pERK1/2 were strongly reduced at 5
and 10 days post treatment. The reason and the functional
consequences for such a reduced pERK signaling are
unknown and remain to be evaluated. It has been reported
that digoxin increases phosphorylation of protein kinase
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AMP-activated catalytic subunit alpha 1 (AMPK) and may
thus affect energy levels in cells.27 In retinas of digoxin-
treated mice, however, pAMPK levels remained constant with
a slight decrease by 5 and 10 days after the last injection. In
contrast, proteins indicating reactive gliosis and degeneration
(GFAP and CASP1) were induced primarily between 2 and
10 days, and thus after the initial signaling events. A late
response of CASP1 was also observed in other models of
retinal degeneration.28 As in the light damage model and
during degeneration in the VPP mouse model for inherited
degeneration,28 we did not detect P10 or P20 cleaved forms
of CASP1 (not shown). Levels of the p85 regulatory subunit of
PI3K remained at constant levels, even though this protein is
known to be involved in Na,K-ATPase signaling.29,30 Levels of
hypoxia-inducible factor 1A (HIF1A) were bi-phasic with an
initial decline at 1 d, followed by an increase until 10 d post
treatment. Although ERG data (Figure 4) may indicate that
digoxin application resulted in a condition resembling retinal
ischemia, we did not detect increased HIF1A levels shortly
after treatment presumably because digoxin can inhibit
HIF1A, as reported by others.31,32 Only after clearance of
digoxin, HIF1A levels may increase and reach the levels
detected between 2 and 10 days. However, this bi-phasic
appearance of HIF1A was not reflected by corresponding
mRNA levels of HIF1 target genes suggesting that HIF1
activity was not strongly affected by digoxin (data not shown).
Figure 1 Digoxin-induced retinal degeneration. (a) Retinal morphology of mice at 2 days after the last of 1, 2 or 3 injections of 2 mg/kg digoxin as indicated. TUNEL staining
(right panel) at 1 day after the last of 3 injections of 2 mg/kg digoxin. (b) Retinal morphology of mice at 2 days after the last of 3 injections of 0.1, 0.5, 1 or 2 mg/kg digoxin as
indicated. (c) Retinal morphology of mice at 6 h, 1 d, 2 d, 5 d and 10 d after the last of 3 injections of 2 mg/kg digoxin as indicated. N= 3. Black arrow, macrophage; Ctrl, PBS-
injected control mice; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium; ROS, rod outer segments; RIS, rod inner
segments; Scale bars, 50 μm; white arrowheads: pyknotic nuclei
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Dependency on rhodopsin. As digoxin-induced retinal
degeneration might be used as a model to study degenerative
processes, we tested the susceptibility of different mouse
strains to degeneration. Similar to C57BL/6 mice, photorecep-
tors of 129S6 wild-type mice were strongly damaged 2 days
after the last injection of digoxin (3×2 mg/kg; Figure 6a).
Surprisingly, however, photoreceptors of Rpe65R91Wmice on a
129S6 genetic background were completely insensitive to
digoxin treatment (Figure 6b). Similarly, photoreceptors of
Rpe65–/– mice that are on a C57BL/6 background were also
not damaged (Figure 6c). Common to these two mouse strains
is the reduced amount (in Rpe65R91W) or lack (in Rpe65–/–) of
bleachable rhodopsin caused by the low activity or complete
absence, respectively, of RPE65 in the RPE.33 Furthermore,
cone photoreceptors of Nrl–/– mice did also not degenerate
after digoxin application (Figure 6d). These data suggest that
rhodopsin is required for digoxin-induced photoreceptor
degeneration and that cones may be insensitive to digoxin
cytotoxicity. Therefore, the influence on cone morphology
(Figure 3) and function (Figures 4a and b) observed in
C57BL/6 mice might have been indirectly caused by the
degeneration of rods. Lack of digoxin sensitivity was not due to
reduced expression of Atp1a genes in retinas of the respective
strains since Atp1a1 and Atp1a2 were similarly expressed in
all strains tested. Although the protected transgenic mice
expressed Atp1a3 at lower levels than C57BL/6 mice,
expression was nevertheless similar to the susceptible mice
of the 129S6 strain (Figure 6e).
As degeneration depended on rhodopsin, we tested
whether increased photon absorption would accelerate the
degenerative process in C57BL/6 mice. However, mice that
were kept in cyclic light during treatment and during the 2-day
post-treatment period (light) were damaged similarly to mice
that were kept in constant darkness after the last digoxin
injection (dark). The central retinal region showed similar
levels of pyknotic photoreceptor nuclei and disrupted inner
and outer segments whereas the peripheral retinal areas were
spared independently of the light condition (Figure 6f).
Discussion
We showed that daily intraperitoneal injections of 2 mg/kg
digoxin on 3 consecutive days induced severe retinal
Figure 2 Geographic extent and in vivo imaging of digoxin-induced retinal
degeneration. (a) Dorsoventral retinal panoramas of digoxin- (digoxin, top) or PBS-
treated (ctrl, bottom) mice at 2 days after the last of 3 injections of 2 mg/kg digoxin.
Scale bar, 200 μm. N= 3. (b) Fundus (top) and OCT (bottom) images of digoxin
(digoxin, left) and untreated (ctrl, right) mice at 9 days after the last of 3 injections of
2 mg/kg digoxin. Yellow circles indicate the position of the corresponding OCT
images. White asterisks mark subretinal fluid accumulation. Scale bar, 100 μm. N= 2
Figure 3 Localization of retinal cell markers after digoxin treatment. Retinal
sections of mice at 10 days after the last of 3 injections of 2 mg/kg digoxin (left) or
PBS (ctrl, right) were stained with PNA (green) and antibodies against GNAT1 (red)
(a), VSX2 (green) and POU4F1 (red) (b), CALB1 (green) and CR (red) (c) and GFAP
(green) and IBA1 (red) (d). Ctrl, PBS-injected control mice; GCL, ganglion cell layer;
INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium;
ROS, rod outer segments; RIS, rod inner segments; Scale bars, 100 μm. N= 3
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degeneration in wild-type mice. Degeneration was restricted
to photoreceptors of the central retina, depended on the
presence of rhodopsin, activated stress signaling, and
induced genes involved in degeneration, inflammation and
oxidative stress. The dose needed to induce retinal degenera-
tion was 100 to 1000-fold higher than doses used to treat heart
conditions in human patients. Indeed, reports indicate that
patients treated with a daily dose of as little as few μg/kg
digoxin may occasionally experience blurred vision, dyschro-
matopsia and other visual symptoms as adverse effects.19
Whether treatment also cause some photoreceptor toxicity in
patients has not been investigated asmost disturbances seem
reversible at the dose used in clinics.34 In mice, however,
significantly higher doses are required for an effect since
polymorphisms in murine Na,K-ATPases make mice
profoundly more resistant to digoxin.20,35,36
Digoxin was recently shown to inhibit HIF1 in the model of
oxygen-induced retinopathy (OIR)31,32 and suppressed choroidal
neovascularization (CNV) in a model of laser-induced lesions.32
Although both studies used wild-type mice, a digoxin concentra-
tion of 2 mg/kg (as used here) and repetitive intraperitoneal
injections, no cytotoxic effects on photoreceptors were reported.
The reason for this is unclear but may be based on the age of the
mice during treatment. Both OIR studies injected digoxin
betweenPND12andPND17, at a timewhen retinal development
has not yet been completed. In fact, photoreceptor function is
very low at least up to PND1637 suggesting that Na,K-ATPases
may not yet be fully functional at this time. Although Yoshida
et al.32 also used adult mice in their model of laser-induced CNV,
they analyzed treatment outcome in choroidal flat mounts
focusing on neovascularization. A specific effect on photorecep-
tors was not investigated in their experiments.
Figure 4 Retinal function after digoxin treatment. Mice received a toxic dose (three injections, 2 mg/kg each) or a subtoxic dose (two injections, 2 mg/kg each) of digoxin and
were analyzed at 10 or 1 day after the last injection, as indicated. (a) Scotopic (top) and photopic (bottom) ERG traces were recorded from mice treated with the toxic digoxin dose
(3 × digoxin, blue lines). (b) Scotopic (top) and photopic (bottom) ERG traces were recorded from mice treated with the subtoxic digoxin dose (2 × digoxin, red lines). ERGs were
compared to mice injected twice with PBS (ctrl) and analyzed 1 day after the second injection (black lines in a and b). Shown are traces averaged from N= 3 mice (6 eyes). (c)
Scotopic a- and b-wave and photopic b-wave amplitudes plotted as a function of stimulus intensity. Shown are averages±S.D. N= 3 mice (6 eyes). Color scheme as in (a and b)
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Digoxin inhibits primarily the catalytic alpha subunits of
Na,K-ATPases14 and has a certain selectivity for α2 and α3
isoforms7 that are also expressed in retinal cells including
photoreceptors.17,38 As Na,K-ATPases are responsible for ion
homeostasis and are critical for maintaining high extracellular
levels of Na+ and high intracellular K+,39 inhibition of
Na,K-ATPase activity by digoxin leads to an increase in Na+
and a depletion of K+ in the cells.39,40 As a consequence of
high intracellular Na+, the entry-mode of the sodium/calcium
exchanger (NCX) may be activated41 potentially causing
increased intracellular Ca2+ levels in addition.42 Whereas a
causative role of high intracellular Na+ for the induction of cell
death has not been established but may be connected to
apoptosis through the regulation of cell volume,43 Ca2+ has
long been recognized as an important factor for the regulation
of a variety of cellular processes including apoptosis.44 Ca2+
may induce cell death, for example, through activation of
calpains that leads to the proteolytic cleavage of intrace-
llular substrates.45 Importantly, calpain-mediated cell death
has also been reported in models of photoreceptor
degeneration.46,47 Similarly, strong evidence suggests that
depletion of intracellular K+ is essential for the initiation of
apoptosis in a variety of cells.48 The mechanisms that
contribute to cell death by K+ depletion are not known in
detail, but may include regulation of cell volume, caspase
activation and changes of the membrane potential of
mitochondria.39 Loss of intracellular K+ was directly implicated
in photoreceptor degeneration in drosophila that lacked the
alpha subunit of the Na,K-ATPase.49 Thus, inhibition of
Na,K-ATPases may alter intracellular ion homeostasis, which
may significantly contribute to the degeneration of
photoreceptor cells after digoxin application.
Increasing evidence suggests that Na,K-ATPases not only
control cellular ion homeostasis but have also important
functions in signal transduction50 by interacting with endo-
genous cardenolides including digoxin-like substances that
are found in the circulation.51,52 Signaling may include
activation of mitogen-activated protein kinases including
ERK1/2,53 activation of PI3K and AKT29 and phosphorylation
of SRC.54 Na,K-ATPases may thus constitute a class of cell
surface receptors that can influence a number of physiological
processes linked to cell survival in several cell types50
including neurons.55 We detected slight upregulation of
pERK1/2 and pAKT at 1–2 days after digoxin injection. As
digoxin has a half-life of ~ 40 h in patients,56 it is likely that
digoxin can still signal at this time point in mice. However, as
ERK1/2 and AKT are also activated by degenerative pro-
cesses, we cannot discriminate between a direct digoxin-
mediated effect and stress response signaling. It is interesting
to note that both, pERK1/2 and pAMPK, levels drop below
control levels late during the degenerative process. The
reason for this is unclear but may signify the specific
consequences of digoxin treatment.
Figure 5 Retinal gene and protein expression after digoxin treatment. (a) Relative expression of genes encoding the alpha subunits of Na,K-ATPases. (b) Relative expression
of genes involved in stress signaling and inflammation, as indicated. Retinal expression levels of digoxin-treated mice (gray bars) were normalized to Actb and expressed as fold
change relatively to PBS-injected controls (ctrl, black bars, set to 1). Shown are means± S.D. of N= 3. *: adjusted P-valueo0.05. **: adjusted P-valueo0.01. ***: adjusted
P-valueo0.001. One-way ANOVA with Dunnett’s multiple comparison test (each column compared to control). (c) Retinal levels of selected proteins and phospho-proteins were
tested by Western blotting. All analyses were done at five time points (as indicated) after the last of 3 injections of 2 mg/kg digoxin and compared to PBS-injected controls (ctrl).
N= 3
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Interestingly, photoreceptor degeneration caused by digoxin
resembles light-induced retinal degeneration in several points.
(i) degeneration is confined to photoreceptors57 (Figures 1
and 3); (ii) the central retina is more sensitive to damage57
(Figure 2); (iii) similar signaling pathways are activated58,59
(Figure 5); (iv) cones are less sensitive60 (Figure 6); and (v)
degeneration depends on rhodopsin61,62 (Figure 6). The latter
point is intriguing and not easily explained. Although hypoth-
eses remain highly speculative, this result may indicate either
an interaction of digoxin with rhodopsin inducing cytotoxicity
Figure 6 Dependency of digoxin-induced degeneration on rhodopsin. Retinal morphology of 129S6 wild type (a), Rpe65R91W (b), Rpe65–/– (c) and Nrl–/– (d) mice at 2 days
after the last of 3 injections of 2 mg/kg digoxin or of PBS (ctrl). N= 3–4 (digoxin) and N= 2–4 (ctrl). (e) Relative basal expression of Atp1a1, Atp1a2 and Atp1a3 in mice of the
different strains as indicated. Expression levels were normalized to Actb and expressed relatively to levels in C57BL/6 mice (black bars, set to 1). Shown are means±S.D. of
N= 3. **: adjusted P-valueo0.01. ***: adjusted P-valueo0.001. N= 3. One-way ANOVA with Dunnett’s multiple comparison test (each column compared to C57BL/6).
(f) Retinal morphology of 129S6 wild type at 2 days after the last of 3 injections of 2 mg/kg digoxin. Mice were either kept in darkness after the last injection according to the
standard protocol (dark) or were exposed to a regular 12 h : 12 h light–dark cycle (light, 60 lux during the light period). N= 3. Ctrl, PBS-injected control mice; GCL, ganglion cell
layer; INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium; ROS, rod outer segments; RIS, rod inner segments; Scale bars, 50 μm
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by an unknown mechanism or an augmentation of digoxin-
induced cell stress by light absorption, for example by
generating all-trans-retinal as a reactive aldehyde63 or
reactive oxygen species.64 However, digoxin-induced degen-
eration did not notably differ between mice that were kept in
darkness or exposed to normal cycling light after digoxin
treatment (Figure 6f), making the first or an alternative
explanation more likely. In any case, both light exposure and
digoxin application cause altered intracellular ratios of
Na+/Ca2+/K+ through closure of the cGMP-gated channels or
inhibition of Na,K-ATPases, respectively. This leads to dege-
nerative processes with several common features suggesting
that maintenance of ion homeostasis is a crucial determinant
of photoreceptor survival. Studying this model in more detail
may shed light onto the regulation of ion homeostasis in
connection to physiologic (signaling) and pathologic (degen-
eration) processes. This model may also provide an alter-
native to the induction of photoreceptor apoptosis by the highly
toxic MNU that was used frequently to investigate cellular and
molecular aspects of photoreceptor degeneration.
Material and Methods
Mice and digoxin injections. All animal experimentation was performed in
accordance to the ARVO Statement for the use of animals in ophthalmic and vision
research and the regulations of the veterinary authorities of Zürich. C57BL/6 (wild
type; Jackson lab, Sulzfeld, Germany), 129S6 (wild type; Taconic, Ejby, Denmark),
Nrl–/–,65 Rpe65–/– (ref. 66) and Rpe65R91W (ref. 33) mice were housed in the animal
facility of the University of Zürich in a 12 h : 12 h light–dark cycle with access to
food and water ad libitum. Three mice per strain and experimental condition were
used at the age of 6–10 weeks, unless indicated otherwise.
Digoxin (Sigma, Buchs, Switzerland) was dissolved at a concentration of
40 mg/mL in DMSO, followed by dilution with PBS to 2 mg/mL and stored in aliquots
at − 20 °C. Immediately before use, digoxin was further diluted in PBS to 0.2 mg/ml
and injected intraperitoneally at doses ranging from 0.1 mg/kg to 2 mg/kg. Injections
were done once a day at 9–10 am for up to 3 consecutive days. Mice that were
injected with PBS served as controls, except for Figure 2b where uninjected mice
were used as controls. During digoxin treatment, mice were housed in normal cages
in a 12 h : 12 h light–dark cycle (60 lux at cage level) with unrestricted access to food
and water. After the last injection, mice were placed in darkness for 2 days before they
were either killed or returned to the light–dark cycle until analysis. For the generation
of data shown in Figure 6f (light), mice were kept in the normal light–dark cycle for the
entire duration of the experiment.
Morphology. Eyes were marked nasally, enucleated, fixed in glutaraldehyde
(2.5% in cacodylate buffer) over night at 4 °C, trimmed, post-fixed in 1% osmium
tetroxide and embedded in Epon 812 as described.67 Dorsoventral cross-sections of
0.5 μm were cut through the optic nerve head, stained with toluidine blue and
analyzed using light microscopy (Zeiss, Axioplan, Jena, Germany). Images of higher
magnifications (Figures 1 and 6) were always acquired from the central region close
to the optic nerve head, except where stated otherwise.
Immunofluorescence and TUNEL staining. Eyes were marked nasally,
enucleated and prepared for cryosectioning essentially as described68 but without
prior perfusion of the mice. Cryosections (12 μm) were cut in a dorsoventral
orientation, blocked for 1 h with blocking solution containing 3% normal goat
serum (Sigma) and 0.3% Triton X-100 (Sigma) in PBS. Sections were incubated
over night at 4 °C with the following primary antibodies: PNA-FITC (1:250, L7381,
Sigma), rabbit anti-GNAT1 (1:500, sc-389, Santa Cruz Biotechnology; Santa Cruz,
CA, USA), mouse anti-GFAP (1:250, G3893-Clone G-A-5, Sigma), rabbit
anti-IBA1 (1:500, 019-19741, Wako, Neuss, Germany), mouse anti-POU4F1
(alias BRN3A; 1:100, MAB1585, Chemicon, Temecula, CA, USA), rabbit anti-VSX2
(alias CHX10; 1:500, kindly provided by Connie Cepko, Harvard University, MA,
USA), mouse anti-CR (1:1000, AB5054, Chemicon) and rabbit anti-CALB1 (1:500,
AB1778, Chemicon). Sections were washed with PBS, incubated for 1 h at room
temperature with appropriate secondary antibodies labeled with Cy2 or Cy3
(Jackson ImmunoResearch Laboratories, Soham, UK), counterstained with
4′,6′-diamidino-2-phenylindole (DAPI; Life Technologies, Zug, Switzerland) and
analyzed using fluorescence microscopy (Zeiss).
For TUNEL staining, retinal cryosections were dried and fixed in 4% PFA solution
for 10 min. After two washing steps with PBS (10 min each) a drop of 0.1% Triton
X-100 in 0.1% sodium citrate was added and incubated for 5 min for tissue
permeabilization. After two washing steps with PBS (5 min each) sections were
tested for TUNEL-positive signals using the in situ cell death detection kit (Roche
Diagnostics, Rotkreuz, Switzerland) according to the manufacturer’s instructions.
Slides were mounted with Mowiol (Sigma), sealed with nail polish solution and
analyzed by fluorescence microscopy. Images were always acquired from the central
region close to the optic nerve head.
RNA isolation and semi-quantitative real-time PCR. Retinas were
isolated through a slit in the cornea and snap frozen in liquid nitrogen. Retinal RNA
was isolated using an RNA isolation kit according to the manufacturer’s instructions
(RNeasy, Qiagen, Hilden, Germany) with an additional on-column DNAse treatment
to digest remaining genomic DNA. Concentration of eluted RNA was measured by
Nanodrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) and
RNA diluted to a final concentration of 50 ng/μl. cDNA was prepared from total RNA
using oligo(dT) and M-MLV reverse transcriptase (Promega, Dübendorf, Switzer-
land). Semi-quantitative real-time PCR was performed in a LightCycler480
instrument (Roche Diagnostics) using the SYBR Green I master mix (Roche
Diagnostics) and appropriate primer pairs (Table 1) designed to span large intronic
regions and avoid known SNPs. Reactions were normalized to Actb and relative
expression was calculated by the comparative threshold cycle method (ΔΔCT)
using the LightCycler480 software.
Protein isolation and Western blot. Retinas were isolated through a slit in
the cornea and homogenized by sonication in 200 μl of 100 mM Tris/HCl (pH 8,0).
Homogenates were centrifuged (1000 × g; 3 min) and protein contents determined
in the supernatants using Bradford reagent (Bio-Rad, Hercules, CA, USA).
SDS–PAGE and Western blot analysis were performed as described67 using the
following primary antibodies: rabbit anti-pERK (1 : 1000, #9101, New England
Biolabs, Herts, UK), rabbit anti-ERK (1 : 1000, #9102, New England Biolabs), rabbit
Table 1 Primers used for real-time PCR
Gene Forward 5′–3′ Reverse 5′–3′ Product (bp)
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153
Atp1a1 GGTGGTGCTCTCTGCTGTAG GACGACATCCTCCGCATTGA 161
Atp1a2 CTGTCCTTGGATGAGCTGGG CCTGAGCTCGCTGATTGGTG 72
Atp1a3 GAACTTCACCACAGACAACC GACCATGATGACCTTGATGC 121
Edn2 AGACCTCCTCCGAAAGCTG CTGGCTGTAGCTGGCAAAG 64
Fgf2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG 158
Casp1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC 138
Tnf CCACGCTCTTCTGTCTACTGA GGCCATAGAACTGATGAGAGG 95
Hmox1 CCGCCTTCCTGCTCAACATT GACGAAGTGACGCCATCTGTG 99
Gfap CCACCAAACTGGCTGATGTCTAC TTCTCTCCAAATCCACACGAGC 240
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anti-pAKTSer473 (1:1000, #9271, Cell Signaling Technology, Danvers, MA, USA);
rabbit anti-pSTAT1Tyr701 (1:500, #9171, Cell Signaling Technology); rabbit
anti-pSTAT3Tyr705 (1:500, #913 L, Cell Signaling Technology); rabbit anti-pAMPKa1-
/2Thr172 (1:1000, sc-33524, Santa Cruz Biotechnology); rabbit anti-CASP1
(1:10 000, kindly provided by P. Vandenabeele, University of Gent, Gent, Belgium);
mouse anti-GFAP (1:1000, G3893-Clone G-A-5, Sigma); rabbit anti-HIF-1 A
(1:4000, NB100-479, Novus Biologicals, Cambridge, UK); rabbit anti-PI3K (1:4000,
D0669, Upstate, Millipore, Darmstadt, Germany); mouse anti-ACTB (1:10,000,
A5441, Sigma). Membranes were incubated with primary antibodies diluted (as
indicated) in 5% non-fat blocking milk (Bio-Rad) in TBST over night at 4 °C with
gentle agitation. After a 1-h incubation step with appropriate HRP-conjugated
secondary antibodies, immunoreactive signals were detected using the Western
lightning chemiluminescence reagent (PerkinElmer, Waltham, MA, USA). Signals
were visualized using X-ray films.
Electroretinography, fundus imaging and OCT. Mice were dark
adaptated over night and pupils dilated using Cyclogyl 1% (Alcon Pharmaceuticals,
Fribourg, Switzerland) and Neosynephrine 5% (Ursapharm Schweiz GmbH,
Roggwil, Switzerland) 20 min before recording. Mice were anesthetized by a
subcutaneous injection of ketamine (85 mg/kg, Parke-Davis, Berlin, Germany) and
Xylazine (4 mg/kg, Bayer AG, Leverkusen, Germany). A drop of mydriacticum
dispersa (OmniVision AG, Neuhausen, Switzerland) was applied to each cornea to
induce mydriasis and to keep the tissue moist. Recordings were done using flashes
of 13 different light intensities ranging from − 50 db (0.000025 cd*s/m2) to 15 db
(79 cd*s/m2) for scotopic and flashes of 8 different light intensities ranging from
− 10 db (25 cd*s/m2) to 25 db (790 cd*s/m2) for photopic ERG as described.69 Ten
recordings were averaged per light intensity.
Fundus imaging and OCTwere done essentially as described.70 In brief, pupils of
mice were dilated and mice anesthetized as describe as above. Eyes were kept moist
with 2% methocel (OmniVision AG) and fundus images and OCT scans recorded
using the Micron IV system (Phoenix Research Labs, Pleasanton, CA, USA).
Statistical analysis. Differences in gene expression levels were evaluated by
one-way ANOVA followed by Dunnett’s multiple comparison tests (GraphPad, San
Diego, CA, USA) comparing all time points (Figures 5a and b) or strains (Figure 6e)
to the control or C57BL/6, respectively.
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